VP 16 carboplatinum in neuroblastoma: a SFOP phase II study. The Société Française d'Oncologie Pédiatrique.
Frappaz
D
D
Centre L. Bérard, Lyon, France.
Michon
J
J
Hartmann
O
O
Bouffet
E
E
Gentet
J C
JC
Chastagner
P
P
Sariban
E
E
Brugière
L
L
Rubie
H
H
Lejars
O
O
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use / Q000633:toxicity*; D016190:Carboplatin / Q000008:administration & dosage / Q000633:toxicity*; D002675:Child, Preschool; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage / Q000633:toxicity*; D005260:Female; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000188:drug therapy* / Q000473:pathology
D005047:Etoposide; D016190:Carboplatin